Reviewer name: Maria LoadesSo who was this reviewer suggesting that the study should be viewed as 'feasibility' and what was the motivation? It sounds like someone with an agenda to sell the feasibility concept.
Reviewer:
I struggle to understand from the aims of the study and the way the study is described whether this was intended as a feasibility study – i.e. to look at feasibility (can this be done?), acceptability (how do participants experience it?) and to give some indication of potential effect sizes to power a future larger scale trial, or whether this was intended as a fully powered trial. Throughout, I think this needs to be clarified for the reader and interpretations/conclusions drawn in light of what the aim was.
Author's response:
Thank you. We agree – this study should be regarded a feasibility study, and the manuscript has been rephrased accordingly
I'm not a native english speaker, but from the excerpt of her peer review I read it as she is clarifying what a feasability trial is to the authors, not saying this should be a feasability trial.So who was this reviewer suggesting that the study should be viewed as 'feasibility' and what was the motivation? It sounds like someone with an agenda to sell the feasibility concept.
Reviewer name: Maria Loades
Institution and Country: University of Bath, UK
Competing interests: None declared.
I'm not a native english speaker, but from the excerpt of her peer review I read it as she is clarifying what a feasability trial is to the authors, not saying this should be a feasability trial.
She has published papers with Chalder and Crawley on CFS: https://researchportal.bath.ac.uk/en/persons/maria-loades/publications/
I'd be interested if you could clarify that please. In my world of engineering feasibility studies sometimes make sense when wanting to assess if an idea is worth further researching/developing, and if it is, helping convince the bean counters it is worth their while stumping up the cash to do so.Yes, but the whole concept of 'feasibility trial' is crap (as David would say).
Or maybe both are to blame?That was not an editorial oversight. If your authors lie, that's on them
And they changed parts of the aim of the study when they rewrote it. In the article with the qualitative interviews the study is listed as: "Malik S, Asprusten TT, Pedersen M, et al. Music therapy combined with cognitive behavior therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: An explorative randomized trial. BMC Research Notes. Submitted."Or maybe both are to blame?
The 1st version of the submitted manuscript's title was "... an explanatory randomized trial".
https://bmjpaedsopen.bmj.com/content/bmjpo/4/1/e000620.draft-revisions.pdf
But in the peer review history provided by the journal, it appears already with the title "....a feasiblity study"
https://bmjpaedsopen.bmj.com/content/bmjpo/4/1/e000620.reviewer-comments.pdf
It's odd in many ways: That a reviewer needs to explain to the authors what a feasibility study is -- when the title implies that it's an "explanatory randomized trial" and that the part of the title indicating the nature of the research could just be changed etc.
Exactly. She was asking for clarification because what they wrote was a muddle. She wasn't asking them to lie.I'm not a native english speaker, but from the excerpt of her peer review I read it as she is clarifying what a feasability trial is to the authors, not saying this should be a feasability trial.
Or maybe both are to blame?
I'd be interested if you could clarify that please. In my world of engineering feasibility studies sometimes make sense when wanting to assess if an idea is worth further researching/developing, and if it is, helping convince the bean counters it is worth their while stumping up the cash to do so.
Why is that so different in the world of medical trials?
Exactly. Their response is evidence of research misconduct. That was not an editorial oversight. If your authors lie, that's on them.
Exactly. She was asking for clarification because what they wrote was a muddle. She wasn't asking them to lie.
I've forgotten some of the details with this paper, but generally it's best for people to avoid talking about lying in CFS research unless they've got really clear supporting evidence imo.